Cryptosporidiosis: Difference between revisions
Jump to navigation
Jump to search
m Changes made per Mahshid's request |
|||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 6: | Line 6: | ||
}} | }} | ||
{{Cryptosporidiosis}} | {{Cryptosporidiosis}} | ||
{{About1|Cryptosporidium parvum}} | |||
{{CMG}} {{AE}} {{KD}} | {{CMG}} {{AE}} {{KD}} | ||
| Line 33: | Line 33: | ||
[[Cryptosporidiosis case study one|Case #1]] | [[Cryptosporidiosis case study one|Case #1]] | ||
| Line 44: | Line 42: | ||
[[Category:Parasitic diseases]] | [[Category:Parasitic diseases]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
Latest revision as of 17:30, 18 September 2017
For patient information click here Template:DiseaseDisorder infobox
|
Cryptosporidiosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cryptosporidiosis On the Web |
|
American Roentgen Ray Society Images of Cryptosporidiosis |
This page is about clinical aspects of the disease. For microbiologic aspects of the causative organism(s), see Cryptosporidium parvum.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Kalsang Dolma, M.B.B.S.[2]
Overview
Historical Perspective
Pathophysiology
Epidemiology and Demographics
Risk Factors
Causes
Differentiating Cryptosporidiosis
Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings
Treatment
Medical therapy | Primary Prevention
Case Studies
Template:Protozoal diseases cs:Kryptosporidióza